IGC PHARMA, INC.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-1.9M | $-2.8M | $-4.6M | $-3.0M | $-2.3M | $-7.8M | $-20.2M |
| Depreciation & Amortization | $396.3K | $728.7K | $781.5K | $712.3K | $673.9K | $996.4K | $785.1K |
| Depreciation | — | — | — | $712.3K | $673.9K | $996.4K | $785.1K |
| Amortization | — | — | — | — | — | — | — |
| Stock-Based Compensation | $250.6K | $214.3K | $833.1K | $181.0K | $824.8K | $-23.3K | — |
| Net Cash from Operating Activities | $-1.4M | $-157.7K | $-2.6M | $-1.7M | $564.8K | $-5.0M | $-2.6M |
| Investing Activities | |||||||
| Capital Expenditures | $145.7K | $122.2K | $76.5K | $8.5K | $326.1K | $5.5K | $285.4K |
| Business Acquisitions | $0 | $-16.4K | $-165.9K | $0 | $0 | $-2.7M | — |
| Net Cash from Investing Activities | $-241.4K | $-183.4K | $-518.1K | $3.1K | $-74.7K | $4.7M | $-44.7K |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $707.6K | $1.0M | $2.9M | $1.7M | $27.7K | $-625.8K | $3.4M |
| Net Change in Cash | $-952.7K | $666.2K | $-202.1K | $-37.9K | $501.5K | $-1.0M | $740.4K |
| Free Cash Flow | $-1.5M | $-279.9K | $-2.7M | $-1.8M | $238.8K | $-5.0M | $-2.9M |